Response to “Genetic diagnosis and prophylactic surgery, an ethical challenge” written by Dr. Rosa A. Pace, in relation to an article I authored on genetic diagnosis of familial medullary thyroid carcinoma.

Article Sidebar

PDF (Spanish)
Published: 2005-06-10
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v25i1.1264

Main Article Content

Patricia Fainstein Day
Servicio de Endocrinología, Metabolismo y Medicina Nuclear. Hospital Italiano de Buenos Aires, Argentina

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 25 No. 1 (2005): Revista del Hospital Italiano de Buenos Aires

Section

Letter to editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Fainstein Day P. Response to “Genetic diagnosis and prophylactic surgery, an ethical challenge” written by Dr. Rosa A. Pace, in relation to an article I authored on genetic diagnosis of familial medullary thyroid carcinoma. Rev Hosp Ital B.Aires [Internet]. 2005 Jun. 10 [cited 2026 Apr. 27];25(1):4-5. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1264

References

Pace RA. Diagnóstico genético y cirugía profiláctica, un desafío éti-co. Rev. Hosp. Ital. B.Aires 2004; 24: 46-47. DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v24i2.1211

Fernández Gianotti T, Fainstein Day P, Russo Picasso MF y col. Carcinoma medular de tiroides familiar (CMTF): primera familia descriptacon CMTF asociado a la mutación Cys611Trp del proto-oncogen RET.Rev. Hosp. Ital. B.Aires 2004; 24: 8-11

Brandi ML, Gagel RF, Angeli A y col. Guidelines for diagnosis andtherapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86:5658-71 DOI: https://doi.org/10.1210/jc.86.12.5658

Melvin KEW, Miller HH, Tashijian AH Jr. Early diagnosis of medullarycarcinoma of the thyroid gland by means of calcitonin assay. N Engl JMed 1971; 285: 1115-20 DOI: https://doi.org/10.1056/NEJM197111112852004

Wolfe HJ, Melvin KEW, Cervi-Skinner SJ y col. C-cell hyperplasiapreceding medullary thyroid carcinoma. N Engl J Med 1973; 289: 437-41 DOI: https://doi.org/10.1056/NEJM197308302890901

Graze K, Spiler IJ, Tashijan AH Jr y col. Natural history of familialmedullary thyroid carcinoma: effect of a program for early diagnosis. NEngl J Med 1978; 299: 980-5 DOI: https://doi.org/10.1056/NEJM197811022991804

Gagel RF, Tashijian AH Jr, Cummings T y col. The clinics outcome ofprospective screening for multiple endocrine neoplasia type 2a: a 18 yearexperience. N Engl J Med 1988; 318: 478-84 DOI: https://doi.org/10.1056/NEJM198802253180804

Mulligan LM,Kwork JB, Healey CS. Germ-line mutations of the RETproto-oncogen in multiple endocrine neoplasia type 2A. Nature 1993;363: 458-60. DOI: https://doi.org/10.1038/363458a0

Donnis Keller H, Dou S, Chi D y col. Mutations in the Ret proto-oncogen are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2: 851-6. DOI: https://doi.org/10.1093/hmg/2.7.851

Wells SA Jr, Chi DD, Toshima K y col. Predictive DNA testing andprophylactic thyroidectomy in patients at risk for multiple endocrineneoplasia type 2A. Ann Surg 1994; 220: 237-50 DOI: https://doi.org/10.1097/00000658-199409000-00002

Lips CJM, Landsvater RM, Hoppener JW y col. Clinical screeningas compared with DNA analysis in families with multiple endocrine neo-plasia type 2A. N Engl J Med 1994; 331: 828-35. DOI: https://doi.org/10.1056/NEJM199409293311302

Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignantprogression of hereditary medullary thyroid cancer. N Engl J Med 2003;349: 1517-25 DOI: https://doi.org/10.1056/NEJMoa012915